ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,463.54
      0.08%
      US Tech 100
      18,493.20
      -0.14%
      Dow Jones
      40,539.93
      -0.12%
      Brent Oil
      78.875
      -0.34%
      Bitcoin
      66,599.18
      -0.34%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Neurogene Inc (NGNE)

      7. Neurogene Inc (NGNE) Financials

      Neurogene Inc

      Neurogene Inc (NGNE)

      NASDAQ
      41.35
      -3.48
      (-7.76%)
      Closed July 29 4:00PM
      Delayed by 15 minutes
      41.35
      0.00
      (0.00%)
      After Hours: 5:14PM
      Delayed by 15 minutes

      Neurogene Inc Financial Summary

      The current NGNE market cap is 536.73M. The company's latest EPS is USD -2.7979 and P/E is -1.25.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -15.14M-3.07M-5.57M-31.82M-18.78M
      Net Income -14.2M-2.09M-4.53M-15.5M-16.92M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 07.83M000
      Operating Income -70.96M-33.73M-60.7M-59.1M-55.58M
      Net Income -69.44M-33.28M-60.69M-57.56M-36.32M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 98.46M94.01M89.59M222.57M195.35M
      Total Liabilities 17.1M14.43M14.35M36.55M24.57M
      Total Equity 81.36M79.58M75.24M186.02M170.78M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 147.02M210.52M163.26M115.95M222.57M
      Total Liabilities 5.34M19.3M20.4M21.62M36.55M
      Total Equity 141.69M191.22M142.86M94.33M186.02M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -13.03M-17.08M-21.35M-51.42M-21.65M
      Investing 10.71M10.3M8.68M25.64M29.94M
      Financing -66k-360k-361k92.48M-6.52M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -15.39M-24.58M-47.56M-45.61M-51.42M
      Investing -688k-2.22M-3.26M-59.13M25.64M
      Financing 82.24M77.14M732k161k92.48M

      Stats and Ratios

      Market Cap 536.73M
      Price to Earnings Ratio -1.25
      Price to Sales Ratio 0
      Price to Cash Ratio 0.31
      Price to Book Ratio 0.24
      Dividend Yield -

      Share Statistics

      Shares Outstanding 12.98M
      Average Volume (1 week) 133.18k
      Average Volume (1 Month) 128k
      52 Week Change 183.80%
      52 Week High 53.00
      52 Week Low 12.49
      Spread (Intraday) 5.3 (11.7%)

      Company Info

      Company Name Neurogene Inc
      Address corporation trust center 1209 orange st
      wilmington, delaware 19802
      Website https://www.neoleukin.com
      Industry pharmaceutical preparations (2834)